On January 23, 2019, Agenus Inc. (NasdaqCM:AGEN) closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.73 USD | +0.17% | +15.88% | +7.08% |
06-28 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
06-28 | Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.08% | 372M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+45.89% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- AGEN Stock
- News Agenus Inc.
- Agenus Inc. announced that it has received $30 million in funding from Gilead Sciences, Inc.